SCHEMBL23861487

SCHEMBL23861487

CC(c1ccc2ccccc2c1)(c1c(O)ccc2ccc(O)cc12)c1c(O)ccc2ccc(O)cc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.46
▸ ESR1 P03372 3/20 0.41
▸ ESR2 Q92731 3/20 0.41
▸ MCL1 Q07820 1/20 0.40
▸ HSD17B2 P37059 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ GAA P10253 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ MPL P40238 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ ALOX5 P09917 2/20 0.37
▸ HSP90AA1 P07900 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ ALPL P05186 1/20 0.37
▸ ALPI P09923 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ ALPG P10696 1/20 0.37
▸ CASP3 P42574 1/20 0.37
▸ RECQL P46063 1/20 0.37
▸ MMP14 P50281 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23861639 0.90 CYP1A2 (0.49) CYP1A2ESR1ESR2HSD17B2MEN1
SCHEMBL23861638 0.89 POLB (0.44) CYP1A2ESR1ESR2HSD17B2MEN1
SCHEMBL23861567 0.88 ESR1 (0.41) ESR1ESR2MCL1HSD17B2MEN1
SCHEMBL23861444 0.86 ESR1 (0.50) CYP1A2ESR1ESR2MCL1HSD17B2
SCHEMBL23082042 0.84 ESR1 (0.48) CYP1A2ESR1ESR2HSD17B2GAA
SCHEMBL23861411 0.83 ESR1 (0.41) CYP1A2ESR1ESR2HSD17B2LMNA
SCHEMBL23861563 0.79 PTPN22 (0.48) CYP1A2ESR1ESR2HSD17B2MEN1
SCHEMBL23861632 0.79 MEN1 (0.43) CYP1A2ESR1ESR2MCL1MEN1
SCHEMBL9618414 0.78 ESR1 (0.47) ESR1ESR2MCL1HSD17B2MEN1
SCHEMBL19806848 0.78 ESR1 (0.42) CYP1A2ESR1ESR2MCL1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method RER1, NBAS, INTS9 CYP1A2 2085/4885ESR1 713/4885ESR2 1033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback